Wells Fargo & Company Mallinckrodt PLC Transaction History

Wells Fargo & Company

  • $434 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 15, 2023
BUY
N/A
4 Added 0.01%
53,138 $0
Q1 2023

May 12, 2023
SELL
N/A
-156,025 Reduced 74.6%
53,134 $0
Q4 2022

Feb 13, 2023
BUY
$0.0 - $15.9 $0 - $3.33 Million
209,159 New
209,159 $0

Others Institutions Holding MNKPF

# of Institutions
1
Shares Held
35K
Call Options Held
0
Put Options Held
0
View Full List

About Mallinckrodt plc

MNKPF Quotes by TradingView
  • Ticker MNKPF
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 13,170,900
  • Description
  • Mallinckrodt plc develops, manufactures, markets, and distributes specialty pharmaceutical products and therapies in the United States, Europe, the Middle East, Africa, and internationally. It operates in two segments, Specialty Brands and Specialty Generics. The company markets branded pharmaceutical products for autoimmune and rare diseases in...
More about MNKPF
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email